Skip to main content

Principal Healthcare Innovators Index ETF (BTEC)

NASDAQ: BTEC · IEX Real-Time Price · USD
48.77 0.79 (1.65%)
Dec 8, 2021 4:00 PM EST - Market closed
Assets$106.82M
NAV$47.47
Expense Ratio0.42%
PE Ratio23.18
Shares Out2.25M
Dividend (ttm)$0.22
Dividend Yield0.45%
Ex-Dividend DateDec 17, 2020
1-Year Return
Volume3,479
Open48.20
Previous Close47.98
Day's Range48.20 - 49.02
52-Week Low44.30
52-Week High44.30
Beta1.20
Holdings339
Inception DateAug 19, 2016

About BTEC

The investment seeks to provide investment results that closely correspond, before expenses, to the performance of the Nasdaq Healthcare Innovators Index (the index). Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies that compose the index at the time of purchase. The index uses a quantitative model designed to identify equity securities in the Nasdaq US Benchmark Index that are small and medium capitalization U.S. healthcare companies.

Asset ClassEquity
SectorLarge Cap
RegionNorth America
IssuerPrincipal Financial Group
Stock ExchangeNASDAQ
Ticker SymbolBTEC
Index TrackedNASDAQ U.S. Healthcare Innovators Index

Top 10 Holdings

24.47% of assets
NameSymbolWeight
CenteneCNC3.97%
SeagenSGEN3.23%
Alnylam PharmaceuticalsALNY2.91%
InsuletPODD2.65%
BioMarin PharmaceuticalBMRN2.08%
Teladoc HealthTDOC2.06%
ViatrisVTRS1.98%
AbiomedABMD1.90%
Exact SciencesEXAS1.86%
Elanco Animal HealthELAN1.83%
View More Holdings

Dividends

Ex-DividendAmountPay Date
Oct 1, 2021$0.000Oct 6, 2021
Jul 1, 2021$0.000Jul 7, 2021
Apr 1, 2021$0.000Apr 7, 2021
Dec 17, 2020$0.21542Dec 22, 2020
Dec 15, 2017$0.05134Dec 20, 2017
Full Dividend History

News

Can Biotech ETFs Gain From Positive Booster Update?

In an effort to combat the coronavirus outbreak and accelerate the distribution process of extra doses in the United States, the FDA has approved the vaccine booster shots.

Other symbols:BBHFBTIBBXBI
1 month ago - Zacks Investment Research

Biotech ETFs to Benefit From Latest Booster Update

The U.S. government's plans to make COVID-19 vaccine booster shots available from next month will likely increase the profits of vaccine makers.

Other symbols:BBHFBTIBBXBI
3 months ago - Zacks Investment Research

Delta Variant Surge Brings Biotech ETFs in Focus

The biotech sector seems like a lucrative investment space as the delta variant of coronavirus continues to spread.

Other symbols:BBHFBTIBBXBI
4 months ago - Zacks Investment Research

9 Best Biotech ETFs to Play High-Octane Trends

Biotechnology is a dynamic but often volatile industry. These biotech ETFs provide a lower-risk way to invest in the space.

5 months ago - Kiplinger

4 ETF Areas Surged Last Week

These four ETF areas were winners last week.

Other symbols:AMLPAMZABDRYBUGGNOM
5 months ago - Zacks Investment Research

Top-Performing Biotech ETFs of Last Week

Investors may want to tap the bullishness in the sector with the best biotech ETFs of last week.

5 months ago - Zacks Investment Research

Goldman Sachs Likes These Health Tech Stocks

Broadly speaking, the healthcare sector is generally viewed as defensive, but there growing pockets of disruption and innovation in the space, including health technology equities. For investors looking...

5 months ago - ETF Trends

Biotech ETFs to Suffer as US Backs IP Waiver for COVID-19 Vaccines

The Biden administration recently informed about supporting the waiver of intellectual property protections for COVID-19 vaccines that has been proposed by South Africa and India.

Other symbols:BBHFBTIBBXBI
7 months ago - Zacks Investment Research

Top COVID-19 Vaccine Stories of April Put Biotech ETFs in Focus

Let's take a look at some top coronavirus vaccine stories of April and the possible impact they can have on biotech ETFs.

7 months ago - Zacks Investment Research

An ETF to Home In on Innovative Health Care Growth

An exchange traded fund that tracks healthcare and technology themes can help diversify and enhance investment portfolios. In the recent webcast, Investing for tomorrow, today: Exploring the future of h...

7 months ago - ETF Trends

Investing for Tomorrow, Today: Exploring the Future of Health Care

In the upcoming webcast, Investing for tomorrow, today: Exploring the future of health care, Steve Jones, Client Portfolio Manager, Principal Global Systematic Solutions; Jeffrey Schwarte, Portfolio Man...

7 months ago - ETF Trends

Top COVID-19 Vaccine Stories of March Put Biotech ETFs in Focus

Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence with multiple mutants.

Other symbols:BBHFBTIBBXBI
8 months ago - Zacks Investment Research

Health Tech x Remote Work: Principal's BTEC ETF

The coronavirus pandemic altered the healthcare landscape and how and where people work. The Principal Healthcare Innovators Index ETF (BTEC) is an exchange traded fund at the epicenter of those themes.

8 months ago - ETF Trends

AI Can Drive the Next Generation of Healthcare Innovation

When it comes to innovation, healthcare is a sector-level leader, especially when the Principal Healthcare Innovators Index ETF (BTEC) taps into that trend. BTEC seeks to provide investment results that...

8 months ago - ETF Trends

Biotech ETFs Pop Amid Pending J&J Vaccine Approval

Biotech ETFs are climbing Wednesday as the Food and Drug Administration's staff endorsed Johnson & Johnson's coronavirus vaccine for emergency use, a key step in offering a third vaccination to the U.S....

Other symbols:IBB
9 months ago - ETF Trends

Bank on BTEC in the Ever-Elusive Search for Healthcare Innovation

The Principal Healthcare Innovators Index ETF (BTEC) became quite the story among healthcare exchange traded funds last year. BTEC seeks to provide investment results that closely correspond, before exp...

9 months ago - ETF Trends

A Guide to Biotech ETF Investing Amid the Coronavirus Crisis

The biotech space had an impressive run on the bourses in 2020 as the coronavirus pandemic triggered a race to roll out vaccine and treatment.

10 months ago - Zacks Investment Research

Moderna Helps Biotech ETFs Mitigate Massive Losses as Stocks Tumble

While much of the stock market and associated index ETFs are bathed in red to start the new year, Moderna is rallying, as the biotech company is boosting its vaccine output to help the spiking infection...

11 months ago - ETF Trends

Top-Performing Biotech ETFs Amid the COVID-19 Crisis

The coronavirus pandemic triggered a race to introduce vaccine and treatment, thereby opening up new investing opportunities in the biotech sector in 2020.

Other symbols:ARKGGNOMIDNAXBI
11 months ago - Zacks Investment Research

Principal on Trends in Portfolio Construction Amid 2020 Volatility

ETF Trends CEO Tom Lydon spoke with Ed Nini, Global Head of Product Strategy for Principal Global Investors, about the tumultuous year that has been 2020 and what kinds of strategies have been put into ...

Other symbols:PQDIPREFUSMC
11 months ago - ETF Trends

The BTEC ETF: Access to Consistent Healthcare Innovation

Bolstered by positioning that includes exposure to companies fighting the coronavirus pandemic, the Principal Healthcare Innovators Index ETF (BTEC) is a pleasant surprise among healthcare exchange trad...

1 year ago - ETF Trends

Principal's BTEC ETF Luring Investors Seeking Telemedicine Exposure

The Principal Healthcare Innovators Index ETF (BTEC) is often viewed as an exchange traded fund with access to biotechnology stocks and companies working on coronavirus vaccines. That's true, but the fu...

1 year ago - ETF Trends

ETF Opportunities Abound in an Increasingly Monolithic Healthcare Industry

With progress being made on the coronavirus vaccine front, the Principal Healthcare Innovators Index ETF (BTEC) is an example of a healthcare exchange traded fund getting into its groove. Fortunately, t...

1 year ago - ETF Trends

Best Biotech ETFs for Q1 2021

The best biotech ETFs for Q1 2021 are ARKG, BTEC, and IDNA.

Other symbols:ARKGIDNA
1 year ago - Investopedia

The Intensifying Vaccine Race Spells Success for BTEC

The race to bringing a coronavirus vaccine to market is heating up. That spells opportunity for the Principal Healthcare Innovators Index ETF (BTEC).

1 year ago - ETF Trends